午夜精品乱人伦小说区,高清国产av一区二区三区,99精品一区二区三区无码吞精,亚洲AV麻豆AⅤ无码电影

您好,歡迎進(jìn)入上海力敏實(shí)業(yè)有限公司網(wǎng)站!
一鍵分享網(wǎng)站到:
您現(xiàn)在的位置:首頁 >> 產(chǎn)品中心 >> 生化試劑、抗體、血清 >> 抗體/蛋白 >> santacruz SC-81805Talin-1 Antibody (YQ-16)

Talin-1 Antibody (YQ-16)

  • 更新時(shí)間:  2023-07-25
  • 產(chǎn)品型號(hào):  santacruz SC-81805
  • 簡單描述
  • mouse monoclonal IgG3 provided at 100 µg/ml
    recommended for detection of Talin-1 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA
詳細(xì)介紹

SANTA CRUZ BIOTECHNOLOGY, INC.
Talin-1 (YQ-16): sc-81805
Santa Cruz Biotechnology, Inc. 1.800.457.3801 831.457.3800 831.457.3801 Europe +00800 4573 8000 49 6221 4503 0 www.scbt.com
BACKGROUND
Focal adhesions were identified as areas within the plasma membrane of
tissue culture cells that adhere tightly to the underlying substrate. In vivo,
these regions are involved in the adhesion of cells to the extracellular matrix.
Paxillin and vinculin are cytoskeletal, focal adhesion proteins that are components
of a protein complex that links the Actin network to the plasma
membrane. Vinculin binding sites have been identified on other cytoskeletal
proteins, including Talin-1 and α-actinin. In addition, vinculin, Talin-1, Talin-2
and α-actinin each contain Actin binding sites. Expression of vinculin, Talin-1
and Talin-2 have been shown to be affected by the level of Actin expression.
α-actinin has been shown to link Actin to integrins in the plasma membrane
through interactions with the vinculin and Talin complex or by a direct interaction
with integrin. Talin-2 is similar to Talin-1 but shows distinct patterns of
expression and cannot compensate for the loss of Talin-1.
REFERENCES
1. Burridge, K., et al. 1988. Focal adhesions: transmembrane junctions
between the extracellular matrix and the cytoskeleton. Annu. Rev. Cell
Biol. 4: 487-525.
2. Gilmore, A.P., et al. 1992. Further characterization of the Talin-binding site
in the cytoskeletal protein vinculin. J. Cell Sci. 103: 719-731.
3.Wood, C.K., et al. 1994. Characterisation of the paxillin-binding site and
the C-terminal focal adhesion targeting sequence in vinculin. J. Cell Sci.
107: 709-717.
4. Gluck, U., et al. 1994. Modulation of α-actinin levels affects cell motility
and confers tumorigenicity on 3T3 cells. J. Cell Sci. 107: 1773-1782.
5. Schevzov, G., et al. 1995. Impact of Actin gene expression on vinculin,
Talin, cell spreading, and motility. DNA Cell Biol. 14: 689-700.
6. Hemmings, L., et al. 1996. Talin contains three Actin-binding sites each of
which is adjacent to a vinculin-binding site. J. Cell Sci. 109: 2715-2726.
7. Gilmore, A.P., et al. 1996. Regulation of vinculin binding to Talin and Actin
by phosphatidyl-inositol-4-5-bisphosphate. Nature 381: 531-535.
CHROMOSOMAL LOCATION
Genetic locus: TLN1 (human) mapping to 9p13.3; Tln1 (mouse) mapping to
4 B1.
SOURCE
Talin-1 (YQ-16) is a mouse monoclonal antibody raised against recombinant
Talin-1 of human origin.
PRODUCT
Each vial contains 100 μg IgG3 in 1.0 ml PBS with < 0.1% sodium azide and
0.1% gelatin.
STORAGE
Store at 4° C, **DO NOT FREEZE**. Stable for one year from the date of
shipment. Non-hazardous. No MSDS required.
APPLICATIONS
Talin-1 (YQ-16) is recommended for detection of Talin-1 of mouse, rat and
human origin by Western Blotting (starting dilution 1:200, dilution range
1:100-1:1000), immunoprecipitation [1-2 μg per 100-500 μg of total protein
(1 ml of cell lysate)], immunofluorescence (starting dilution 1:50, dilution
range 1:50-1:500), immunohistochemistry (including paraffin-embedded
sections) (starting dilution 1:50, dilution range 1:50-1:500) and solid phase
ELISA (starting dilution 1:30, dilution range 1:30-1:3000).
Suitable for use as control antibody for Talin-1 siRNA (h): sc-36610, Talin-1
siRNA (m): sc-36611, Talin-1 shRNA Plasmid (h): sc-36610-SH, Talin-1 shRNA
Plasmid (m): sc-36611-SH, Talin-1 shRNA (h) Lentiviral Particles: sc-36610-V
and Talin-1 shRNA (m) Lentiviral Particles: sc-36611-V.
Molecular Weight of Talin-1: 230 kDa.
Positive Controls: RAW 264.7 whole cell lysate: sc-2211.
RECOMMENDED SECONDARY REAGENTS
To ensure optimal results, the following support (secondary) reagents are
recommended: 1) Western Blotting: use goat anti-mouse IgG-HRP: sc-2005
(dilution range: 1:2000-1:32,000) or Cruz Marker™ compatible goat antimouse
IgG-HRP: sc-2031 (dilution range: 1:2000-1:5000), Cruz Marker™
Molecular Weight Standards: sc-2035, TBS Blotto A Blocking Reagent:
sc-2333 and Western Blotting Luminol Reagent: sc-2048. 2) Immunoprecipitation:
use Protein A/G PLUS-Agarose: sc-2003 (0.5 ml agarose/2.0 ml).
3) Immunofluorescence: use goat anti-mouse IgG-FITC: sc-2010 (dilution
range: 1:100-1:400) or goat anti-mouse IgG-TR: sc-2781 (dilution range:
1:100-1:400) with UltraCruz™ Mounting Medium: sc-24941. 4) Immunohistochemistry:
use ImmunoCruz™: sc-2050 or ABC: sc-2017 mouse IgG
Staining Systems.
DATA
SELECT PRODUCT CITATIONS
1. Ah Kioon, M.D., et al. 2010. Adrenomedullin increases fibroblast-like synoviocyte
adhesion to extracellular matrix proteins by upregulating integrin
activation. Arthritis Res. Ther. 12: R190.
RESEARCH USE
For research use only, not for use in diagnostic procedures.

 

上海力敏實(shí)業(yè)有限公司代理santacruz產(chǎn)品,咨詢 
上海力敏實(shí)業(yè)有限公司代理santazruz產(chǎn)品,咨詢 


留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說明:

  • 驗(yàn)證碼:

    請輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
无码国产精品一区二区高潮| 久久久无码中文字幕久...| 揄拍成人国产精品视频| 永久免费av网站| 边做边爱mp3在线播放免费观看 | 两个人在线观看视频| 色综合久久久久久久久五月| 丁香五香天堂网| 小婷又软又嫩又紧水又多 | 国产AV办公室丝袜系列| 久久无码人妻一区二区三区午夜| 狠狠亚洲婷婷综合色五月五月色| 人妻无码αv中文字幕久久琪琪布| 色翁荡熄又大又硬又粗又视频 | 无码人妻一区二区三区| 国产老师色诱我好爽在线观看| 免费无码又爽又刺激网站| 亚洲熟伦熟女专区| 麻豆成人久久精品二区三区免费| 久久精品国产清自在天天线 | 久久精品国产精品亚洲毛片| 99蜜桃臀久久久欧美精品网站| 久久久精品欧美一区二区三区| 女人被男人吃奶到高潮| 欧美特黄a级高清免费大片a片| 亚洲欧洲无码AV电影在线观看| 亚洲av本道一区二区三区四区 | 免费无码又色又爽的视频软件| 香蕉久久一区二区不卡无毒影院 | 精品久久久久久亚洲中文字幕 | 无码h黄肉3d动漫在线观看 | 欧美精品乱码99久久蜜桃| 久久久久国产综合av天堂| 国产农村妇女作爱视频播放| 国产精品99久久精品爆乳| 国产激情无码一区二区APP| 超碰97久久国产精品牛牛 | 国产精品h片在线播放| av无码专区| 久久精品中文字幕| 久久人妻少妇嫩草av蜜桃|